Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250711066447N1Phase 3Recruiting
Phase 3, randomised, double-blind trial in vasomotor symptoms and night sweats comparing Pregabalin with Fluoxetine (2 arms). Primary endpoints: Hot flashes and Night sweats. Started Nov 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250711066447N1.